NASDAQ:INOV - Inovalon Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$12.59 -0.01 (-0.08 %)
(As of 03/20/2019 03:24 PM ET)
Previous Close$12.60
Today's Range$12.34 - $12.73
52-Week Range$8.90 - $15.57
Volume18,384 shs
Average Volume692,453 shs
Market Capitalization$1.92 billion
P/E Ratio70.11
Dividend YieldN/A
Beta0.68
Inovalon Holdings, Inc., a technology company, provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models in the healthcare industry. The company's platform enables the assessment and enhancement of clinical and quality outcomes and financial performance. It serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. The company provides technology that supports approximately 500 healthcare organizations. Its platforms are informed by data pertaining to approximately 932,000 physicians; 455,000 clinical facilities; and approximately 240 million individuals and 37 billion medical events. Inovalon Holdings, Inc. has a collaboration agreement with Anthem, Inc. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland.

Receive INOV News and Ratings via Email

Sign-up to receive the latest news and ratings for INOV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Data processing & preparation
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:INOV
CUSIPN/A
Phone301-809-4000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$527.68 million
Cash Flow$0.8393 per share
Book Value$4.48 per share

Profitability

Net Income$-39,160,000.00

Miscellaneous

Employees2,499
Market Cap$1.92 billion
Next Earnings Date5/14/2019 (Estimated)
OptionableOptionable

Inovalon (NASDAQ:INOV) Frequently Asked Questions

What is Inovalon's stock symbol?

Inovalon trades on the NASDAQ under the ticker symbol "INOV."

How were Inovalon's earnings last quarter?

Inovalon Holdings Inc (NASDAQ:INOV) released its quarterly earnings results on Wednesday, February, 20th. The technology company reported $0.05 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.07 by $0.02. The technology company earned $136.30 million during the quarter, compared to the consensus estimate of $145.20 million. Inovalon had a negative net margin of 7.32% and a positive return on equity of 3.88%. The firm's revenue was up 18.9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.06 earnings per share. View Inovalon's Earnings History.

When is Inovalon's next earnings date?

Inovalon is scheduled to release their next quarterly earnings announcement on Tuesday, May 14th 2019. View Earnings Estimates for Inovalon.

What guidance has Inovalon issued on next quarter's earnings?

Inovalon issued an update on its first quarter earnings guidance on Wednesday, February, 20th. The company provided earnings per share (EPS) guidance of $0.07 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.07. The company issued revenue guidance of $143-146 million, compared to the consensus revenue estimate of $146.84 million.

What price target have analysts set for INOV?

3 brokerages have issued 1 year price objectives for Inovalon's stock. Their predictions range from $11.00 to $22.00. On average, they anticipate Inovalon's stock price to reach $15.3333 in the next twelve months. This suggests a possible upside of 21.5% from the stock's current price. View Analyst Price Targets for Inovalon.

What is the consensus analysts' recommendation for Inovalon?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inovalon in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Inovalon.

Has Inovalon been receiving favorable news coverage?

Headlines about INOV stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Inovalon earned a coverage optimism score of 0.7 on InfoTrie's scale. They also assigned headlines about the technology company a news buzz of 7.0 out of 10, indicating that recent press coverage is likely to have an effect on the stock's share price in the near term.

Who are some of Inovalon's key competitors?

What other stocks do shareholders of Inovalon own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inovalon investors own include General Electric (GE), Micron Technology (MU), Pfizer (PFE), AcelRx Pharmaceuticals (ACRX), Inovio Pharmaceuticals (INO), Alibaba Group (BABA), FireEye (FEYE), Opko Health (OPK), Genworth Financial (GNW) and ConforMIS (CFMS).

Who are Inovalon's key executives?

Inovalon's management team includes the folowing people:
  • Keith R. Dunleavy, Chairman & CEO (Age 50)
  • Mr. Robert A. Wychulis, Pres (Age 64)
  • Mr. John Michael Burgin, Chief Product Officer (Age 45)
  • Mr. Jonathan R. Boldt, Chief Financial Officer (Age 34)
  • Mr. Jason B. Capitel, Chief Operating Officer (Age 47)

When did Inovalon IPO?

(INOV) raised $500 million in an IPO on Thursday, February 12th 2015. The company issued 22,200,000 shares at a price of $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank served as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers.

Who are Inovalon's major shareholders?

Inovalon's stock is owned by a number of of institutional and retail investors. Top institutional investors include FMR LLC (4.40%), BlackRock Inc. (3.44%), Northern Trust Corp (0.63%), Riverbridge Partners LLC (0.60%), Geode Capital Management LLC (0.53%) and Geode Capital Management LLC (0.53%). Company insiders that own Inovalon stock include Jason Capitel, Joseph R Rostock, Keith R Dunleavy, Lee D Roberts, Robert A Wychulis and Shauna L Vernal. View Institutional Ownership Trends for Inovalon.

Which institutional investors are selling Inovalon stock?

INOV stock was sold by a variety of institutional investors in the last quarter, including Prescott Group Capital Management L.L.C., Penn Davis Mcfarland Inc., Cowen Prime Services LLC, Riverbridge Partners LLC, Two Sigma Advisers LP, Raymond James Financial Services Advisors Inc., MetLife Investment Advisors LLC and Northern Trust Corp. View Insider Buying and Selling for Inovalon.

Which institutional investors are buying Inovalon stock?

INOV stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, D. E. Shaw & Co. Inc., BlackRock Inc., Geode Capital Management LLC, Geode Capital Management LLC, Bank of New York Mellon Corp, Rhumbline Advisers and PEAK6 Investments LLC. Company insiders that have bought Inovalon stock in the last two years include Jason Capitel, Keith R Dunleavy and Lee D Roberts. View Insider Buying and Selling for Inovalon.

How do I buy shares of Inovalon?

Shares of INOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Inovalon's stock price today?

One share of INOV stock can currently be purchased for approximately $12.62.

How big of a company is Inovalon?

Inovalon has a market capitalization of $1.93 billion and generates $527.68 million in revenue each year. The technology company earns $-39,160,000.00 in net income (profit) each year or $0.18 on an earnings per share basis. Inovalon employs 2,499 workers across the globe.

What is Inovalon's official website?

The official website for Inovalon is http://www.inovalon.com.

How can I contact Inovalon?

Inovalon's mailing address is 4321 COLLINGTON ROAD, BOWIE MD, 20716. The technology company can be reached via phone at 301-809-4000 or via email at [email protected]


MarketBeat Community Rating for Inovalon (NASDAQ INOV)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  233 (Vote Outperform)
Underperform Votes:  292 (Vote Underperform)
Total Votes:  525
MarketBeat's community ratings are surveys of what our community members think about Inovalon and other stocks. Vote "Outperform" if you believe INOV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INOV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel